Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Aventis plasma-derived products

Executive Summary

Labeling for Monoclate-P, Mononine, Gammar-P I.V., Albuminar-5, Albuminar-20 and Albuminar-25 has been revised to note that the plasma-derived products have undergone polymerase chain reaction testing for viruses. The new labeling states that "the plasma used in the manufacture of this product has been tested and found negative for HBV, HCV, and HIV-1, by an investigation test procedure referred to as nucleic acid testing (NAT) using polymerase chain reaction (PCR) technology"

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036020

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel